Upcoming Events

Get a preview of this year’s RAPS Convergence, hosted by a special panel of peers who have the behind-the-scenes details to get you ready — and excited — for Charlotte.

The 62nd AESGP Annual Meeting will bring together regulators, policymakers, industry leaders, and innovators to address the most pressing developments shaping the future of self-care in Europe.

Join RAPS Boston for an in-person Executive Chat with Diane Rocco, SVP of Global Regulatory Affairs at Biogen, moderated by Ami Mehr. The discussion will explore how regulatory leadership shapes key decisions across the drug development lifecycle, from early clinical strategy through post-market execution in complex therapeutic areas. The event will also feature a practical discussion featuring case studies moderated by April Nguyen, with speakers Aiden Flynn and Ben Kaspar, focusing on how early cross-functional collaboration, statistical simulations, real-world data, and regulatory engagement strategies can accelerate development, improve outcomes, and enable more confident, evidence-based decision-making.

Learn practical applications and implementation strategies for AI tools in your everyday regulatory affairs and compliance needs

Join the RAPS Twin Cities Chapter for our Annual Symposium, a full-day event bringing together regulatory professionals, industry leaders, and subject matter experts for a comprehensive deep dive into the most critical medical device regulatory topics of 2026. Hosted at Medtronic Headquarters in Minneapolis, Minnesota, this event delivers practical, actionable insights across FDA submissions, biocompatibility, advertising and promotional practices, combination products, EU MDR/IVDR, and more.

QA/RA teams are under pressure to use AI, but validating non-deterministic tools is unclear. This session provides a risk-based framework to define scope, generate audit-ready evidence, and maintain compliance w/o delay.

Attend this two-day conference to discover how linking compliance efforts with real-world performance can transform quality from a checkbox into a competitive advantage.

The ARCS Annual Conference is the premier event for the pharmaceutical and medical technology sectors in Australia, bringing together industry leaders, policy makers, and top‑tier professionals from academia.

The regulatory boundary between "wellness" and "medical device" was fundamentally redefined in January 2026. This panel explores the strategic shift toward Connected Health, examining how recent FDA "Red Tape" cuts and expanded enforcement discretion are accelerating the commercialization of digital health ecosystems, AI-enabled sensors, and remote monitoring platforms.

Join expert speakers and seasoned professionals for an all-day, hands-on workshop where you’ll explore real-world applications of Artificial Intelligence from analysis in support of regulatory intelligence to building custom GPTs and crafting effective prompts. You’ll learn how to identify risks, avoid common pitfalls, and future-proof your RA skill set in a rapidly evolving landscape.

The submission process for Master Notified Body Opinions concerning drug-device combinations as required by EU MDR 2017/745.

Medical Devices and IVDs in Great Britain: Developments to date and what is coming

As the life sciences industry continues to evolve, this event serves as a powerful platform to connect, collaborate, and drive forward transformative solutions.

HLTH Europe is Europe’s #1 healthcare innovation, redefining the future of health.

Expert guidance from regulators and industry to streamline compliance, stay deadline-ready, and advance patient safety through rigorous science

Learn how AI governance in life sciences is evolving. ISO/IEC 42001 offers a practical framework for compliant, risk-based AI management—without overhauling your QMS. Discover how to close the gaps and prepare for what's next.

Join us for a networking event at Strangelove’s in the heart of Philadelphia! Meet regulatory professionals and connect with chapter leaders over happy hour bites.

This webcast identifies common pitfalls in parallel EU IVDR and US FDA regulatory planning for IVD devices and illustrates how early design and development

Join RAPS Boston for an in-depth session unpacking the real world regulatory playbook for AI-enabled wearable devices, from first submission to post-market evolution. Learn from industry leaders Robert Michalik and Tahir Rizvi as they reveal how AI fits within design controls, accelerates development, and reshapes clinical strategy. Gain actionable insights on PCCPs, FDA engagement, and risk mitigation to streamline 510(k) clearance. Leave with a stronger understanding of the AI regulatory landscape and practical insights to support informed decision-making.

This webinar will provide practical insights into evolving EU MDR clinical pathways, with real-world examples and key pitfalls from pre-clinical to post-market phases, including emerging routes like orphan and breakthrough devices.

Join a RAPS San Francisco networking and recruitment series across multiple in-person events. Meet regulatory professionals, connect with chapter leaders, and learn about ambassador and leadership roles. Build your network and support the local regulatory community.

Vorträge und eine Paneldiskussion über die aktuellen regulatorische Anforderungen – von REACH bis CLP – sowie Einblicke in die regulatorische Praxis der AG Stoffregulierung bei SPECTARIS.

This session explores how current regulatory leaders can intentionally shift from being technical experts to becoming talent multipliers within their organizations.